Q2 2022 Holdings
Filed 2022-07-25 | 70 holdings | $40.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cerus Corp(CERS) | COM | 157085101 | $11.1M | 2,093,861 | 27.3% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $7.5M | 539,545 | 18.5% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $7.4M | 820,954 | 18.2% |
| Biogen Inc(BIIB) | COM | 09062X103 | $4.2M | 20,825 | 10.5% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $2.7M | 213,090 | 6.7% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $2.6M | 139,539 | 6.4% |
| Cvrx Inc(CVRX) | COM | 126638105 | $1.8M | 292,145 | 4.3% |
| Codexis Inc(CDXS) | COM | 192005106 | $1.4M | 137,960 | 3.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $979.0K | 36,322 | 2.4% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $566.0K | 53,521 | 1.4% |
| Invesco QQQ TR(QQQ)Put | UNIT SER 1 | 46090E103 | $45.5K | 162,500 | 0.1% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $17.9K | 313,962 | 0.0% |
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $15.5K | 208,300 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $14.4K | 1,562,957 | 0.0% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $14.3K | 718,789 | 0.0% |
| Merus N V | COM | N5749R100 | $10.6K | 469,113 | 0.0% |
| Anavex Life Sciences Corp(AVXL)Put | COM NEW | 032797300 | $9.2K | 917,100 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $9.1K | 418,660 | 0.0% |
| Veru Inc(VERUEUR)Put | COM | 92536C103 | $8.8K | 780,400 | 0.0% |
| Prometheus Biosciences IncPut | COM | 74349U108 | $8.5K | 301,700 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $8.2K | 1,380,111 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $7.2K | 40,787 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $7.1K | 232,630 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $6.9K | 105,277 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR)Call | COM | 60468T105 | $6.8K | 100,900 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $5.9K | 129,795 | 0.0% |
| Alnylam Pharmaceuticals Inc(ALNY)Call | COM | 02043Q107 | $5.8K | 40,000 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $5.8K | 72,187 | 0.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $4.8K | 1,082,304 | 0.0% |
| Contrafect Corp(CFRXUSD)Put | COM NEW | 212326300 | $4.8K | 1,562,900 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $4.2K | 212,482 | 0.0% |
| Iveric BIO Inc(OPHTEUR)Put | COM | 46583P102 | $4.1K | 430,900 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $3.9K | 850,000 | 0.0% |
| Apollo Endosurgery Inc(HQ8F) | COM | 03767D108 | $3.9K | 1,074,879 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $3.8K | 26,374 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $3.8K | 16,227 | 0.0% |
| Immatics N.v(IMTX) | SHS | N44445109 | $3.1K | 355,103 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $2.9K | 10,414 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $2.6K | 104,129 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $2.5K | 260,325 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $2.4K | 36,403 | 0.0% |
| Otonomy Inc | COM | 68906L105 | $2.2K | 1,041,273 | 0.0% |
| Eliem Therapeutics Inc(CLYM) | COM | 28658R106 | $2.2K | 713,009 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $2.1K | 107,852 | 0.0% |
| Phreesia Inc(PHR) | COM | 71944F106 | $2.0K | 78,111 | 0.0% |
| Viewray Inc(VRAYQ) | COM | 92672L107 | $1.9K | 732,740 | 0.0% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $1.9K | 105,476 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $1.9K | 416,479 | 0.0% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $1.6K | 197,640 | 0.0% |
| Humanigen IncPut | COM NEW | 444863203 | $1.4K | 781,100 | 0.0% |